Circulating tumour DNA tests for T790M mutations in non-small cell lung cancer
Topic Status Complete
Circulating tumour DNA tests for T790M mutations in non-small cell lung cancer
Summary
Health Technology Wales researchers searched for clinical and cost effectiveness evidence on circulating tumour DNA tests for T790M mutations in people with advanced or metastatic non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.
Topic Exploration Report
TER516 12.2023
Health Technology Wales Partners
